August 15, 2024
A Tennessee federal judge on Thursday declined to throw out a suit by Novo Nordisk Inc. alleging that DCA Pharmacy is selling drugs with the same active ingredient as its Ozempic diabetes medicine without U.S. Food and Drug Administration authorization.
July 07, 2023
Novo Nordisk has filed a series of lawsuits asking a pair of federal courts to stop various compounding pharmacies from doling out drugs with allegedly the same active ingredient as certain Novo Nordisk brand-name drugs meant to fight diabetes and help with weight loss.